A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Pulmonary Hypertension
Interventions
DRUG

UT-15C

oral

Trial Locations (9)

14623

University of Rochester Medical Center, Mary Parkes Center, Rochester

15213

University of Pittsburgh Medical Center, Pittsburgh

43221

The Ohio State University Medical Center, Columbus

45219

The Carl and Edyth Lindner Research Center at The Christ Hospital, Cincinnati

45267

University of Cincinnati, Cincinnati

85013

St. Joseph's Hospital and Medical Center, Phoenix

87524

University of Arizona, Tucson

90095

University of California Los Angeles Pulmonary Division, Los Angeles

95817

University of California Davis Medical Center, Sacramento

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY